Shots:
- Viz.ai has entered into a multi-year collaboration with Sanofi & Regeneron to deploy and evaluate its AI-powered chronic obstructive pulmonary disease (COPD) workflow solution
- Sanofi, Regeneron, and Viz.ai collaborated on an AI-powered solution to improve care for high-risk COPD pts, focusing on how the Viz COPD module can enhance EHR workflows, access to care, and pts outcomes
- Viz.ai will explore its Viz COPD module, which uses AI and natural language processing to analyze EHR data, identify high-risk COPD patients, and support guideline-based screening, triage, and follow-up care
Ref: Businesswire | Image: Viz.ai & Sanofi & Regeneron| Press Release
Related News:- Regeneron’s Lynozyfic (Linvoseltamab) Receives the EC’s Conditional Approval for R/R Multiple Myeloma
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
